This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
3 Reasons Why Growth Investors Shouldn't Overlook Universal Health Services (UHS)
by Zacks Equity Research
Universal Health Services (UHS) could produce exceptional returns because of its solid growth attributes.
Why Universal Health Services (UHS) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should Value Investors Buy Universal Health Services (UHS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
New Strong Buy Stocks for April 7th
by Zacks Equity Research
ASLE, CALM, DXPE, FET and UHS have been added to the Zacks Rank #1 (Strong Buy) List on April 7, 2025.
Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Community Health Rides on Same-Store Volumes, Streamlining Efforts
by Zacks Equity Research
With improving labor trends, CYH's contract labor expenses are decreasing.
Zacks.com featured highlights include JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology
by Zacks Equity Research
JD.com, Universal Health Services, Fresenius Medical Care and Qifu Technology are part of the Zacks Screen of the Week article.
Universal Health Services (UHS) Up 0.3% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Universal Health Services (UHS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
4 Best Value Stocks With Low PEG to Boost Your Portfolio Returns
by Urmimala Biswas
Here are four PEG-driven value stocks that fit our screening criteria: JD, UHS, FMS, and QFIN.
How Much Upside is Left in Universal Health Services (UHS)? Wall Street Analysts Think 28.75%
by Zacks Equity Research
The average of price targets set by Wall Street analysts indicates a potential upside of 28.8% in Universal Health Services (UHS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Why Universal Health Services (UHS) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health Services (UHS) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
Universal Health Services (UHS) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Should Value Investors Buy Universal Health Services (UHS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why Universal Health Services (UHS) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health Stock Down 26.6% in 6 Months: Should You Buy the Dip?
by Zacks Equity Research
UHS' rising admissions and patient days poise its top line well for growth in the future.
EHC Gains on Sustained Revenue Growth, Expansion Plans
by Zacks Equity Research
Encompass Health benefits from strong patient volumes, continued expansion endeavors across the United States and a robust 2025 business outlook.
The Zacks Analyst Blog Highlights United Airlines, Carnival, Synchrony Financial, NVIDIA and Universal Health Services
by Zacks Equity Research
United Airlines, Carnival, Synchrony Financial, NVIDIA and Universal Health Services are part of the Zacks top Analyst Blog.
5 Top-Ranked S&P 500 Stocks to Buy at a Bargain: NVDA, CCL, and more
by Sweta Killa
The S&P 500 logs the worst week since September and tumbles 4.2% the past month. The beaten-down prices offer a buying opportunity for NVDA, UHS, UAL, CCL and SYF.
Pediatrix Medical Stock Rallies 37.7% in 6 Months: More Room to Run?
by Zacks Equity Research
MD is expected to benefit from rising patient volumes, a favorable payer mix and streamlining initiatives.
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should Value Investors Buy Universal Health Services (UHS) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Universal Health Services (UHS) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Universal Health Q4 Earnings Beat on Strong Adjusted Admissions
by Zacks Equity Research
UHS' fourth-quarter earnings benefit from rising admissions and patient days. Higher expenses partially offset the positives.
Universal Health Services (UHS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Universal Health Services (UHS) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.